Clinical Trial Update: Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the combination of dextromethorphan and memantine for Bipolar II disorder; current status is unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Ii Disorder

Drugs mentioned

• Dextromethorphan (dextromethorphan)
• Memantine (memantine)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Bipolar Disorder II | Phase 3 | Status: UNKNOWN